PerkinElmer
Brief PMS299 D

Application Note

Preclinical Fluorescence Imaging of Cancer Metastasis to the Lung and Response to Therapy

TheDeterminationofTotalProtein_512x288.jpg

Introduction

Quantitative pre-clinical fluorescence imaging transcends the boundaries of traditional optical imaging of biological structures and physiology by providing information at the molecular level about disease states and therapeutic response. Fluorescent Pre-clinical Imaging Agents and FMT® (Fluorescence Molecular Tomography) Quantitative Pre-clinical Imaging Systems represent powerful tools for research and drug development in the imaging of biological processes and pharmaceutical activity in living animals.